Concepedia

Michael Wonder

MW

10

Publications

181

Citations

10

H-Index

2006

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (Australia)

IC Independent Consulting (Australia)

Michael Wonder is an author at Novartis (Switzerland) specializing in public health, medicine, and health services research.

Top concepts

MedicinePublic HealthHealth PolicyHealth EconomicsHealth Services ResearchBusinessPharmacotherapyOutcomes ResearchEvidence-based PracticeFinance

Publications per year

2006–2020

10

Publications

10

Early Dialogue Between the Developers of New Technologies and Pricing and Reimbursement Agencies: A Pilot Study

Martin E. Backhouse, Michael Wonder, Edward Hornby et al. · Value in Health · 2011 · 39 citations · Full text

Fintech, New Technologies, Cost Issue +10

Access to new medicines in New Zealand compared to Australia.

Michael Wonder, Richard Milne · PubMed · 2011 · 29 citations

Early Scientific Advice Obtained Simultaneously from Regulators and Payers: Findings from a Pilot Study in Australia

Michael Wonder, Martin E. Backhouse, Edward Hornby · Value in Health · 2013 · 21 citations · Full text

Early Scientific Advice, Public Policy, Experimental Economics +12

Australian Managed Entry Scheme: A New Manageable Process for the Reimbursement of New Medicines?

Michael Wonder, Martin E. Backhouse, Sean D. Sullivan · Value in Health · 2012 · 19 citations

Health Administration, New Medicines, Primary Care +12

Analysis of PBAC submissions and outcomes for medicines (2010–2018)

Sean Lybrand, Michael Wonder · International Journal of Technology Assessment in Health Care · 2020 · 15 citations · Full text

Rows per page

1–5 of 10